• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The clinical course of COVID-19 in systemic sclerosis patients, report from 150 patients.

作者信息

Tamartash Zahra, Javinani Ali, Gharibdoost Farhad, Atef Yekta Reza, Mohammadzadegan Amirmohammad, Kavosi Hoda

机构信息

Rheumatology Research Center, Tehran University of Medical Science (TUMS), 1411713137, Tehran, Iran.

Anesthesiology Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Intern Emerg Med. 2021 Oct;16(7):2001-2003. doi: 10.1007/s11739-021-02727-7. Epub 2021 Apr 16.

DOI:10.1007/s11739-021-02727-7
PMID:33864203
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8051543/
Abstract
摘要

相似文献

1
The clinical course of COVID-19 in systemic sclerosis patients, report from 150 patients.150例系统性硬化症患者的COVID-19临床病程报告
Intern Emerg Med. 2021 Oct;16(7):2001-2003. doi: 10.1007/s11739-021-02727-7. Epub 2021 Apr 16.
2
[The impact of COVID-19 in a cohort of patients with systemic sclerosis].[新型冠状病毒肺炎对一组系统性硬化症患者的影响]
Rev Med Inst Mex Seguro Soc. 2023 Mar 1;61(2):163-171.
3
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management.系统性硬化症与 COVID-19 大流行：世界硬皮病基金会为患者管理提供的初步建议。
Ann Rheum Dis. 2020 Jun;79(6):724-726. doi: 10.1136/annrheumdis-2020-217407. Epub 2020 Apr 29.
4
Immunosuppressive treatment for systemic sclerosis-Therapeutic challenges during the COVID-19 pandemic.系统性硬化症的免疫抑制治疗——新冠疫情期间的治疗挑战
Dermatol Ther. 2020 Jul;33(4):e13619. doi: 10.1111/dth.13619. Epub 2020 Jun 30.
5
From Raynaud Phenomenon to Systemic Sclerosis in COVID-19: A Case Report.从 COVID-19 中的雷诺现象到系统性硬化症：一例报告。
Adv Skin Wound Care. 2022 Feb 1;35(2):123-124. doi: 10.1097/01.ASW.0000795240.63966.53.
6
Acute limb ischemia in an adolescent with COVID-19 and systemic scleroderma: a case report.青少年 COVID-19 合并系统性硬皮病合并急性肢体缺血：病例报告。
BMC Pediatr. 2022 Dec 28;22(1):737. doi: 10.1186/s12887-022-03761-w.
7
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.一名接受托珠单抗治疗系统性硬化症相关间质性肺病的系统性硬化症患者感染了新冠病毒。
Ann Rheum Dis. 2020 May;79(5):668-669. doi: 10.1136/annrheumdis-2020-217442. Epub 2020 Apr 2.
8
Severe skin ulcer in systemic scleroderma due to severe acute respiratory syndrome coronavirus 2 infection.严重急性呼吸综合征冠状病毒2感染所致系统性硬化症中的严重皮肤溃疡
J Dermatol. 2021 Jul;48(7):e343-e344. doi: 10.1111/1346-8138.15920. Epub 2021 Apr 21.
9
COVID-19 vaccine hesitancy in systemic sclerosis.
Clin Exp Rheumatol. 2021 Jul-Aug;39 Suppl 131(4):165-166. doi: 10.55563/clinexprheumatol/vv61xv. Epub 2021 Jul 15.
10
Covid-19 overlapping with systemic sclerosis.新冠病毒与系统性硬化症并存。
Rev Soc Bras Med Trop. 2020 Sep 21;53:e20200450. doi: 10.1590/0037-8682-0450-2020. eCollection 2020.

引用本文的文献

1
Prevalence & Impact of COVID-19 in Systemic Sclerosis Patients and Assessment of the Demographic & Clinical Features in Cases Associated with Worse Prognosis: Results of a Single Centre Registry.新型冠状病毒肺炎在系统性硬化症患者中的患病率及影响以及对预后较差病例的人口统计学和临床特征评估：单中心登记研究结果
Mediterr J Rheumatol. 2023 Jun 30;34(2):172-179. doi: 10.31138/mjr.34.2.172. eCollection 2023 Jun.

本文引用的文献

1
Comparison of the clinical phenotype of systemic sclerosis patients in Iran and France in two university centers.伊朗和法国两个大学中心系统性硬化症患者临床表型的比较。
J Scleroderma Relat Disord. 2019 Jun;4(2):149-159. doi: 10.1177/2397198318809224. Epub 2018 Nov 20.
2
Impact of COVID-19 outbreak in an Italian cohort of patients with systemic sclerosis.新冠疫情对意大利一组系统性硬化症患者的影响。
Ther Adv Musculoskelet Dis. 2020 Sep 24;12:1759720X20953356. doi: 10.1177/1759720X20953356. eCollection 2020.
3
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study.意大利北部风湿性疾病患者中的新型冠状病毒肺炎：一项单中心观察性病例对照研究。
Lancet Rheumatol. 2020 Sep;2(9):e549-e556. doi: 10.1016/S2665-9913(20)30169-7. Epub 2020 Jun 18.
4
COVID-19: the new challenge for rheumatologists. First update.新型冠状病毒肺炎：风湿病学家面临的新挑战。首次更新。
Clin Exp Rheumatol. 2020 May-Jun;38(3):373-382. doi: 10.55563/clinexprheumatol/yvn0nh. Epub 2020 May 26.
5
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies.一系列接受免疫抑制靶向治疗的慢性关节炎患者的 COVID-19 临床病程。
Ann Rheum Dis. 2020 May;79(5):667-668. doi: 10.1136/annrheumdis-2020-217424. Epub 2020 Apr 2.
6
Are my patients with rheumatic diseases at higher risk of COVID-19?我的风湿性疾病患者感染新冠病毒的风险更高吗？
Ann Rheum Dis. 2020 Jun;79(6):839-840. doi: 10.1136/annrheumdis-2020-217322. Epub 2020 Mar 22.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.